Recent Progress in Treating Airway Mucus Hypersecretion by Targeting the Epidermal Growth Factor Receptor Signaling Pathway
Pediatric Discovery · 2026-03 · 4 (1)
DOI: 10.1002/pdi3.70007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Discovery, online erschienen am 10.05.2025. Verfasst von Yuanyuan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine Ministry of Education Key Laboratory of Child Development and Disorders Chongqing Key Laboratory of Pediatrics Chi…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Asthma, chronic pulmonary obstructive disease (COPD), cystic fibrosis, and acute respiratory infections are severe respiratory conditions that significantly contribute to global morbidity and mortality. Airway mucus hypersecretion is an important common pathophysiological and clinical manifestation of these diseases and is closely associated with adverse clinical outcomes. At present, the management of airway mucus hypersecretion lacks a viable clinical intervention. However, the revelation that the EGFR signaling pathway acts as a convergent intracellular pathway for many inflammatory mediators indicates that it exhibits the greatest potential for inhibiting excessive mucus production. This review provides a comprehensive overview of the role of EGFR in airway mucus hypersecretion and the therapeutic progress of targeting it, intending to improve clinicians' understanding of the mechanism and offer insights and recommendations for developing novel pharmaceutical interventions to regulate mucus secretion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine Ministry of Education Key Laboratory of Child Development and Disorders Chongqing Key Laboratory of Pediatrics Children's Hospital of Chongqing Medical University National Clinical Res…
ORCID-Profile: Yuanyuan Zhang, Yu Deng
Zitieren
APA
Zhang, Y., Yang, F., Yan, C., Deng, Y., & Liu, E. (2026). Recent Progress in Treating Airway Mucus Hypersecretion by Targeting the Epidermal Growth Factor Receptor Signaling Pathway. Pediatric Discovery, 4(1). https://doi.org/10.1002/pdi3.70007
Vancouver
Zhang Y, Yang F, Yan C, Deng Y, Liu E. Recent Progress in Treating Airway Mucus Hypersecretion by Targeting the Epidermal Growth Factor Receptor Signaling Pathway. Pediatric Discovery. 2026;4(1). doi:10.1002/pdi3.70007
BibTeX
@article{Zhang2026,
author = {Zhang, Yuanyuan and Yang, Fuping and Yan, Chunyu and Deng, Yu and Liu, Enmei},
title = {Recent Progress in Treating Airway Mucus Hypersecretion by Targeting the Epidermal Growth Factor Receptor Signaling Pathway},
journal = {Pediatric Discovery},
year = {2026},
volume = {4},
number = {1},
doi = {10.1002/pdi3.70007}
}
EUVIMED